 Supply chain resilience in the pharmaceutical industry: a dynamic capabilities approach on the French drug marketLa résilience des supply chains dans l’industrie pharmaceutique: une analyse par les capacités dynamiques des acteurs sur le marché français du médicamentKarine Evrard Samuel ()
Post-Print from HAL Abstract: The Covid-19 pandemic has revealed weaknesses in the pharmaceutical industry's supply chain that predate this crisis and have persisted since then. This article examines the dynamic capabilities mobilised by various players in the pharmaceutical supply chain in France to address drug shortages. The first part of the article sets out the theoretical framework based on the concepts of dynamic capabilities, vulnerability and organisational resilience. Based on this review of the literature and secondary data, the author develops an analytical framework and puts into perspective the actions taken by the four groups of actors identified in the French market. The dynamic capabilities approach allows for a holistic sectoral analysis and highlights the multi-level dynamics, as well as the major role of mechanisms, that combine security and coordination actions. Keywords: Supply chain; resilience; pharmaceutical sector; dynamic capabilities (search for similar items in EconPapers) Published in Logistique & Management, 2025, 33 (4), pp.251-270. ⟨10.1080/12507970.2025.2578271⟩ There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it. Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-05567833 DOI: 10.1080/12507970.2025.2578271 Access Statistics for this paper More papers in Post-Print from HAL |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.